Complete ICD-10-CM coding and documentation guide for Myeloma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Complete code families applicable to Myeloma
Multiple myeloma and malignant plasma cell neoplasms
This range covers the primary ICD-10 codes for multiple myeloma, including active disease, remission, and relapse.
Compare key differences between these codes to ensure accurate selection
Code | Description | When to Use | Key Documentation |
---|---|---|---|
C90.00 | Multiple myeloma not having achieved remission | Use when the patient has active multiple myeloma with no remission. |
|
C90.01 | Multiple myeloma in remission | Use when the patient is in complete remission post-treatment. |
|
C90.02 | Multiple myeloma in relapse | Use when there is a confirmed relapse of multiple myeloma. |
|
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Essential facts and insights about Myeloma
Use when the patient is in complete remission post-treatment.
Document remission status clearly with lab results.
Use when there is a confirmed relapse of multiple myeloma.
Ensure relapse is documented with clinical and lab evidence.
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Hypercalcemia
R17.0Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Monoclonal gammopathy of undetermined significance
D47.2Avoid these common documentation and coding issues when documenting Myeloma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C90.00.
Clinical: Inaccurate treatment planning., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims.
Regularly update patient status in EHR., Ensure lab results are included in documentation.
Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Inaccurate clinical data representation.
Use D47.2 for MGUS/smoldering if no CRAB criteria are present.
Inadequate documentation of remission status can lead to audit issues.
Ensure all remission statuses are supported by lab results and clinical notes.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Common questions about ICD-10 coding for Myeloma, with expert answers to help guide accurate code selection and documentation.
Use these documentation templates to ensure complete and accurate documentation for Myeloma. These templates include all required elements for proper coding and billing.
Need help with ICD-10 coding for Myeloma? Ask your questions below.